✦ LIBER ✦

Predictors of response of U.S. veterans to treatment for the hepatitis C virus

✍ Scribed by Thomas R. Riley III

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 43 KB
Volume: 47
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.22068

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of response of U.S. veterans

Predictors of response of U.S. veterans to treatment for the hepatitis C virus

✍ Lisa I. Backus; Derek B. Boothroyd; Barbara R. Phillips; Larry A. Mole 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

The currently recommended treatment for hepatitis C virus (HCV) infection is pegylated interferon alfa (PEG-INF) and ribavirin, which can be difficult to tolerate. More information about predicting sustained virologic response (SVR) may allow more informed treatment decisions to be made. This retros

Floating density of hepatitis C virus pa

Floating density of hepatitis C virus particles and response to interferon treatment

✍ Sakai, Akito; Kaneko, Shuichi; Matsushita, Eiki; Kobayashi, Kenichi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 1 views

Hepatitis C virus (HCV) particles can be classified into two major fractions according to their floating density in serum. However, the genomic heterogeneity of each fraction and the relationship between this viral characteristic and interferon (IFN) response in patients with chronic hepatitis are n

Predictors of sustained virological resp

Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation

✍ Matteo Cescon; Gian Luca Grazi; Alessandro Cucchetti; Gaetano Vetrone; Matteo Ra 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

Factors associated with sustained virological response (SVR) in patients treated for hepatitis C virus (HCV) recurrence after liver transplantation (LT) are unclear. Ninety-nine HCV-positive/hepatitis B surface antigen-negative patients received antiviral treatment (AVT) with interferon/peginterfero

Development of novel agents for the trea

Development of novel agents for the treatment of hepatitis C virus

✍ Tracy Swan; Raymond T. Chung 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 1 views

Risk of hepatobiliary and pancreatic can

Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans

✍ Hashem B. El-Serag; Eric A. Engels; Ola Landgren; Elizabeth Chiao; Louise Hender 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 2 views

Serum hepatitis C virus RNA level as a p

Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-α therapy in Japanese patients with chronic hepatitis C

✍ Etsuro Onto; Masashi Mizokami; Tatsunori Nakano; Hisahiro Terashima; Osamu Nojir 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

## Abstract Serum hepatitis C virus (HCV) RNA level has been shown to be a good predictor of subsequent response to interferon‐α (IFN) therapy in US patients in whom genotype 1a/1b are both predominant. To determine whether serum HCV RNA level is a predictor of subsequent response to IFN in Japanes